SPL 1.03% 9.8¢ starpharma holdings limited

DEP-Gemcitabine, page-9

  1. 12,941 Posts.
    lightbulb Created with Sketch. 1456
    Interesting don't you think

    Has the penny dropped


    And all of the trials below become obsolete when Starpharma applies it's technology platform with improved formulations

    Current clinical trials using Gemcitabine, Docetaxel, Cabazitaxel, and Irinotecan




    FYI


    Clinical Trials Using Gemcitabine Hydrochloride

    61

    Clinical Trials Using Docetaxel

    102


    Clinical Trials Using Cabazitaxel

    7


    Clinical Trials Using Irinotecan Hydrochloride

    31
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.8¢
Change
0.001(1.03%)
Mkt cap ! $40.97M
Open High Low Value Volume
9.7¢ 9.9¢ 9.7¢ $44.76K 455.2K

Buyers (Bids)

No. Vol. Price($)
1 824859 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 121525 5
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.